Information  X 
Enter a valid email address

BAE SYSTEMS PLC (BA.)

  Print      Mail a friend       Annual reports

Friday 05 April, 2019

BAE SYSTEMS PLC

Director/PDMR Shareholding

RNS Number : 3144V
BAE SYSTEMS PLC
05 April 2019
 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

Peter Lynas

2

 

Reason for the notification

 

a)

 

Position/status

 

Group Finance Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

BAE Systems plc

b)

 

LEI

 

8SVCSVKSGDWMW2QHOH83

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 2.5p each in BAE Systems plc

 

 

 

GB0002634946

b)

 

Nature of the transaction

 

Exercise of options over 28,477 Performance Shares under the Long Term Incentive Plan ("LTIP") and the subsequent sale of 13,418 shares to satisfy income tax and NIC liability.

 

c)

 

Price(s) and volume(s)

 

 

 


Price

Volume

Acquisition of shares on exercise of share option

Nil

28,477

Sale of shares, including those sold to satisfy income tax and NIC liability

£4.95

13,418

Shares retained


15,059

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Exercise

Volume: 28,477

Price GBP: nil

Shares sold, including those sold to satisfy income tax and NIC liability

Volume: 13,418

Price GBP: £66,419.10

e)

 

Date of the transaction

 

 

2019-04-04

f)

 

Place of the transaction

XLON - London Stock Exchange

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHUVAARKAASRAR

a d v e r t i s e m e n t